Crandell Keith's Form 4 filing
Sana Biotechnology, Inc.SANA · filed Feb 12, 2024
- Accession no.
- 0001062993-24-002841
- Filed
- Feb 12, 2024, 5:43 PM ET
- Trade date
- Feb 8, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $10.0M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Crandell KeithCIK 0001219039 | 10% Owner |
| Bybee ClintonCIK 0001219043 | 10% Owner |
| Gillis StevenCIK 0001229592 | 10% Owner |
| Burow KristinaCIK 0001569248 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 8, 2024 | Common Stock | PPurchaseAcquired | +363,637 | $5.50 | +$2,000,003.5 | 10,667,387 | Indirect | Duplicate filing |
| Feb 8, 2024 | Common Stock | PPurchaseAcquired | +727,272 | $5.50 | +$3,999,996 | 12,446,022 | Indirect | Duplicate filing |
| Feb 8, 2024 | Common Stock | PPurchaseAcquired | +727,272 | $5.50 | +$3,999,996 | 12,446,022 | Indirect | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
This Form 4 is one of two reports relating to the same transaction being filed jointly by ARCH IX, AVP IX LP, ARCH IX Overage, AVP IX Overage LP, AVP IX LLC, ARCH X, AVP X LP, ARCH X Overage, AVP X Overage LP, AVP X LLC, Keith Crandell, Clinton Bybee, Kristina Burow and Steven Gillis (collectively, the "Reporting Persons"). Robert Nelsen has direct ownership of Common Stock and is filing his own Form 4 separately.